Nosocomial infection, also known as hospital acquired or associated infection (HAI) is defined as an infection developed in patients during the hospital stay that was earlier not present or incubated during admission in the hospital.
This report contains market size and forecasts of Nosocomial Infection Treatment in Global, including the following market information:
Global Nosocomial Infection Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nosocomial Infection Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibacterial Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nosocomial Infection Treatment include Abbott, Bayer, Becton, Dickinson and Company, Belimed, BioMerieux, Cantel, Cepheid, Getinge Group and Kimberly-Clark Corp., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nosocomial Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nosocomial Infection Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nosocomial Infection Treatment Market Segment Percentages, by Type, 2021 (%)
Antibacterial Treatment
Antiviral Treatment
Antifungal Treatment
Global Nosocomial Infection Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nosocomial Infection Treatment Market Segment Percentages, by Application, 2021 (%)
Ventilator Associated Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
Gastrointestinal Infection
MRSA
Global Nosocomial Infection Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nosocomial Infection Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nosocomial Infection Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nosocomial Infection Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Bayer
Becton, Dickinson and Company
Belimed
BioMerieux
Cantel
Cepheid
Getinge Group
Kimberly-Clark Corp.
Merck & Co
Nordion
Pfizer
Roche
Sakura Seiki
BioMérieux
Steris
Johnson & Johnson
Sterigenics International, Inc.
Halyard Health, Inc.
Advanced Sterilization Products
Matachana Group